Many more CTIX catalysts in December and soon after!
December Catalysts
- Start of cohort 10 (possible dosage increase) - Start of B-OM (phase 2) - Start of K + Cytarabine (phase 1b/2) - FDA meetings on B-ABSSSI & P - Release of B-ABSSSI bottom line data
2015 Q1 Catalysts
- Biotech Showcase (Jan. 12-14) - Start of B-ABSSSI (phase 3) - Start of P (phase 2/3) - Completion of K (phase 1) - Formulations of B-Ocular, B-Otic, diabetic foot infections
Milestones
- Completion of cohort 9 (350 mg/m2) - B-ABSSSI phase 2b positive top-line data - P phase 1 primary endpoint met - Formulation of B stable at room temperature